H.U. Group Holdings, Inc.

Tokyo Stock Exchange 4544.T

H.U. Group Holdings, Inc. Total Non-Current Liabilities for the year ending March 31, 2024: USD 556.80 M

H.U. Group Holdings, Inc. Total Non-Current Liabilities is USD 556.80 M for the year ending March 31, 2024, a -11.42% change year over year. Total non-current liabilities are the sum of long-term debt and other non-current liabilities.

H.U. Group Holdings, Inc. Total Non-Current Liabilities for the year ending March 31, 2023 was USD 628.56 M, a 1.13% change year over year.
H.U. Group Holdings, Inc. Total Non-Current Liabilities for the year ending March 31, 2022 was USD 621.51 M, a -7.66% change year over year.
H.U. Group Holdings, Inc. Total Non-Current Liabilities for the year ending March 31, 2021 was USD 673.04 M, a 18.89% change year over year.
H.U. Group Holdings, Inc. Total Non-Current Liabilities for the year ending March 31, 2020 was USD 566.09 M, a 69.54% change year over year.

Key data

Date	Total Non-Current Liabilities	Shareholders' Equity	Other Liabilities	Total Liabilities

Tokyo Stock Exchange: 4544.T

H.U. Group Holdings, Inc.

CEO	Mr. Shigekazu Takeuchi
IPO Date	Jan. 1, 2001
Location	Japan
Headquarters	Shinjuku Mitsui Building
Employees	5,295
Sector	Health Care
Industries Pharmaceuticals Biotechnology Hospitals & Clinics Medical Instruments

Description

H.U. Group Holdings, Inc., through its subsidiaries, provides laboratory testing products and services in Japan. The company offers lab testing and its related services to medical institutions; self-medication services; food, environment, and cosmetic testing services; and testing services through corporate health insurance associations. It also researches, develops, manufactures, and sells in vitro diagnostic devices, which includes the LUMIPULSE, an automatic chemiluminescent enzyme immunoassay system that offers reagents for infectious disease, cancer, and lifestyle disease to medical institutions and testing centers; and ESPRINE, a rapid diagnostics kit series for influenza, hepatitis B, and the novel coronavirus, as well as supplies ingredients for test drugs. In addition, the company provides support services related to hospital administration work, including aid for surgical procedures and endoscope room work, inspection and maintenance services for medical equipment, and in-hospital logistics management and transportation services; and rents and sells nursing-care equipment and supplies. Further, it offers home-visit nursing care services. The company was formerly known as Miraca Holdings Inc. and changed its name to H.U. Group Holdings, Inc. in July 2020. H.U. Group Holdings, Inc. was incorporated in 1950 and is headquartered in Tokyo, Japan.

Key trends

Past 5 years